A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer’s disease
2011 ◽
Vol 119
(6)
◽
pp. 1330-1340
◽
2020 ◽
Vol 20
(17)
◽
pp. 1522-1534
◽
2005 ◽
Vol 24
(2-3)
◽
pp. 213-218
◽
2008 ◽
Vol 86
(15)
◽
pp. 3265-3274
◽
2007 ◽
Vol 27
(8)
◽
pp. 1981-1991
◽
2006 ◽
Vol 3
(4)
◽
pp. 613-619
◽
2012 ◽
Vol 9
(7)
◽
pp. 864-879
◽
2011 ◽
Vol 2011
◽
pp. 1-9
◽